-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Standardized Mite (Dermatophagoides Pteronyssinus + Dermatophagoides Farinae) Allergen Extract in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Standardized Mite (Dermatophagoides Pteronyssinus + Dermatophagoides Farinae) Allergen Extract in Allergic Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Standardized Mite (Dermatophagoides...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Grass Pollen Allergy in Grass Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Grass Pollen Allergy in Grass Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergen For Grass Pollen Allergy in Grass...
-
Company Insights
Innovation and Patenting activity of Extraction Oil & Gas Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Extraction Oil & Gas Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
NewLikelihood of Approval Analysis for Hemophilia A (Factor VIII Deficiency)
Overview How likely is it that the drugs in Hemophilia A (Factor VIII Deficiency) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemophilia A (Factor VIII Deficiency) Overview Hemophilia A is...
-
Thematic Analysis
NewRobotics in Mining – Thematic Intelligence
Robotics in Mining Thematic Intelligence Report Overview Robots benefit multiple segments of the mining value chain. The integration of robots, including drones, autonomous haulage systems (AHS), and remote-controlled machines, has revolutionized the mining sector. Field robots in mining include AHSs, which transport minerals from the site to processing plants. These are valuable throughout the mining value chain, particularly in extraction and processing. The ‘Robotics in Mining’ thematic intelligence report assesses how robotics can be utilized across the mining industry. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allergen For Allergic Rhinitis in Allergic Rhinitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allergen For Allergic Rhinitis in Allergic Rhinitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergen For Allergic Rhinitis in Allergic Rhinitis Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PHN-031 in Osteoporosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PHN-031 in Osteoporosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PHN-031 in Osteoporosis Drug Details: PHN-031 (PH3) is under development for the prevention...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Alequel in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Alequel in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alequel in Crohn's Disease (Regional Enteritis) Drug Details: Alequel is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EF-001 in Anaplastic Astrocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EF-001 in Anaplastic Astrocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EF-001 in Anaplastic Astrocytoma Drug Details: EF-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EF-001 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EF-001 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EF-001 in Glioblastoma Multiforme (GBM) Drug Details: EF-001 is under development...